Treatment of bleeding with low half-life fibrinogen
    1.
    发明授权
    Treatment of bleeding with low half-life fibrinogen 有权
    治疗低半衰期纤维蛋白原的出血

    公开(公告)号:US08557773B2

    公开(公告)日:2013-10-15

    申请号:US12990643

    申请日:2009-04-29

    IPC分类号: A61K38/36 C07K14/75

    摘要: The invention provides low-half life fibrinogen with reduced sialyation as a result of recombinant expression or enzymatic and chemical removal. The low-half life fibrinogen is useful in treating or effecting prophylaxis of bleeding particularly in situations of an acute nature in which a high initial dose and rapid decline to normal or below normal levels is desirable.

    摘要翻译: 本发明提供低半衰期的纤维蛋白原,由于重组表达或酶促和化学去除而减少了唾液酸化。 低半衰期纤维蛋白原可用于治疗或预防出血,特别是在急性的情况下,其中初始剂量高,正常或正常水平急剧下降。